# MoonLake Immunotherapeutics: Form 8-K, filed Dec 3, 2021

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2021-12-03
- Accepted by EDGAR: Dec 3, 2021, 16:04 ET
- Period: 2021-11-30
- Accession: 0001213900-21-063323
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390021063323/ea151633-8k_helixacq.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390021063323/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390021063323/ea151633-8k_helixacq.htm

Filed Dec 3, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-063323. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
